Strategic Investment Solutions Inc. IL Grows Position in CVS Health Co. (NYSE:CVS)

Strategic Investment Solutions Inc. IL boosted its position in shares of CVS Health Co. (NYSE:CVS) by 77.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,024 shares of the pharmacy operator’s stock after buying an additional 446 shares during the quarter. Strategic Investment Solutions Inc. IL’s holdings in CVS Health were worth $46,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MSH Capital Advisors LLC purchased a new position in shares of CVS Health during the 4th quarter valued at approximately $218,000. Dodge & Cox raised its position in CVS Health by 11.2% during the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock worth $3,147,054,000 after acquiring an additional 7,075,209 shares during the period. Jump Financial LLC lifted its holdings in CVS Health by 3,329.0% during the fourth quarter. Jump Financial LLC now owns 342,903 shares of the pharmacy operator’s stock valued at $15,393,000 after purchasing an additional 332,903 shares in the last quarter. M Holdings Securities Inc. purchased a new stake in shares of CVS Health during the fourth quarter worth about $489,000. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of CVS Health during the 4th quarter worth about $759,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 2.0 %

Shares of CVS opened at $67.19 on Friday. The company’s 50-day moving average price is $66.22 and its 200 day moving average price is $58.76. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $71.45. The firm has a market cap of $84.71 billion, a P/E ratio of 18.36, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, sell-side analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 3.96%. CVS Health’s payout ratio is 72.68%.

Analysts Set New Price Targets

Several equities research analysts have commented on CVS shares. Barclays boosted their price objective on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. Robert W. Baird increased their price objective on CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research note on Tuesday. Wells Fargo & Company lifted their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. Truist Financial increased their target price on shares of CVS Health from $76.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, April 11th. Finally, Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. Four analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $71.83.

Insider Transactions at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Michael F. Mahoney purchased 30,000 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.